Ask an Expert is a free question-and-answer service about breast cancer and breast health that is available on weekends. If you'd like to ask a question or comment, please visit us again on Saturday or Sunday. In the meantime, please search the existing topics using the search tool at the top of the page. It's quite possible that one of our many existing topics already addresses your question.
If you would like a consultation with a breast specialist at the Johns Hopkins Avon Foundation Breast Center, call 443-778-2778. It is possible to get an appointment for a second opinion within a few days of contacting us.
We hope you find the information helpful!
| Forum | Questions | Ask a Question | |
|---|---|---|---|
 |
Hormonal Therapy Questions about Hormonal Therapy. |
2,543 |  |
| Asked | Publicly Submitted Question | ||
|---|---|---|---|
| 3/2/2006 | Four months ago I was diagnosed with DCIS, Stage 0, Low to Intermediate grade. I had a lumpectomy with follow-up radiation. My oncologist wants me to participate in a double blind study with tomaxifen and arimadex. I have atrial fibrillation and am concerned about the tomaxifen. I asked about being placed on arimadex but the Oncologist tells me it has not been approved for DCIS. Is this true? According to my understanding, it is approved. She tells me the only chance I have at arimadex is if I enter the study. | ||
| Replied | JHU's Breast Center Reply | ||
| 3/3/2006 | yes, approved. talk with him more regarding what to expect while taking it. | ||
Please note: This service is not intended to provide primary medical advice concerning specific medical care or treatment. Ask an Expert is a free service operated by health care professionals at the Johns Hopkins Avon Foundation Breast Center. Due to the volume of questions and their complexity, there are times when medical oncologists, surgeons, radiation oncologists or oncology nurses are consulted for their input. These individuals volunteer their time for this service and will respond as soon as they are able. Please do not post or send the same question to us in multiple locations or categories.